Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction
SMFG $3.2 billion senior notes offering
We advised SMFG on its SEC-registered offering of TLAC notes
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
Toyota Motor Credit $2.6 billion notes offering
We advised Toyota Motor Credit on the SEC-registered notes offering
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
Baldwin Group $935 million credit facilities financing
We advised the borrower on the refinancing and amendment
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition